Exact Mass: 460.1205
Exact Mass Matches: 460.1205
Found 49 metabolites which its exact mass value is equals to given mass value 460.1205,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Apremilast, (+/-)-
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
Apremilast
Ponesimod
ParishinE
Parishin E is a natural product found in Gastrodia elata with data available. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1]. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1].
Parishin
Parishin E is a natural product found in Gastrodia elata with data available. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1]. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1].
(R)-4,4-dihydroxy-3-(4-dihydroxyphenyl)spiro{2,10-dioxatricyclo[12.2.2.13,7]nonadeca-1,(16),3,5,7(19),14,17-hexaene-12,2(5H)-furan}-11,5-dione|(R)-4,4-dihydroxy-3-(4-hydroxyphenyl)spiro{2,10-dioxatricyclo[12.2.2.13,7]nonadeca-1(17),3,5,7(19),14(18),15-hexaene-12,2(5H)-furan}-11,5-dione|retipolide E
3,3-Dimethyl-6-hydroxy-9beta-(1-methylethenyl)-11-methoxy-9a,13a-epoxy-3H,7H-4,14-dioxadibenz[a,j]anthracene-7,10,13-trione
6-Chloro-N-[(9H-fluoren-9-ylmethoxy)carbonyl]tryptoph
Apremilast
L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058988 - Phosphodiesterase 4 Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1,3,5-tri-O-benzoyl-2-oxo-α-D-erythro-pentofuranose
Losartan potassium
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents B - Blood and blood forming organs > B03 - Antianemic preparations Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Losartan potassium (DuP-753 potassium) is an angiotensin II receptor type 1 (AT1) antagonist, competing with the binding of angiotensin II to AT1 with an IC50 of 20 nM.
Ponesimod
L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators C308 - Immunotherapeutic Agent
2-(5-{5-[Amino(iminio)methyl]-1H-benzimidazol-2-YL}-2-fluoro-6-oxido-1,1-biphenyl-3-YL)succinate
gammaGluCys(IAN)Gly(1-)
A peptide anion obtained by deprotonation of the carboxy groups and protonation of the free amino group of gammaGluCys(IAN)Glu.
Aspartyl adenylate beta-ketophosphonate isostere
An organic phosphonate that is adenosine having a [(3S)-3-amino-4-carboxy-2-oxobutyl](hydroxy)phosphoryl group attached at position 5.
(5Z)-5-[[3-chloro-4-(2,3-dihydroxypropoxy)phenyl]methylidene]-3-(2-methylphenyl)-2-propylimino-1,3-thiazolidin-4-one
3-[2-hydroxyethyl-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]sulfamoyl]benzoic acid ethyl ester
4-[[3-(3-methoxyphenyl)-3-oxopropylidene]amino]-N-quinoxalin-2-ylbenzenesulfonamide
Octoclothepin (maleate salt)
Octoclothepin maleate salt, an orally active neuroleptic agent, is a dual SR-2A and D2DR inhibitor. Octoclothepin maleate salt reveals an intensive central depressant action in a series of observational and instrumental procedures in rodents[1][2].
